Allena Pharmaceuticals, Inc.

ALNA · NASDAQ
Analyze with AI
6/30/2022
3/31/2022
12/31/2021
9/30/2021
Assets
Cash & Equivalents$6,589$8,895$29,988$40,421
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$9,897$11,302$3,018$1,533
Total Curr. Assets$16,486$20,197$33,006$41,954
Property Plant & Equip (Net)$1,202$1,412$1,628$1,788
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$123$123$123$128
Total NC Assets$1,325$1,535$1,751$1,916
Other Assets$0$0$0$0
Total Assets$17,811$21,732$34,757$43,870
Liabilities
Payables$2,271$3,082$1,030$3,027
Short-Term Debt$380$5,347$317$300
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$7,774$1,687$14,332$4,346
Total Curr. Liab.$10,425$10,116$15,679$7,673
LT Debt$380$0$210$10,167
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$3,265$0$0$0
Total NC Liab.$3,645$8,429$210$10,167
Other Liabilities$0-$8,429$0$0
Cap. Leases$380$454$527$574
Total Liabilities$14,070$10,116$15,889$17,840
Equity
Pref Stock$0$0$0$0
Common Stock$108$90$83$80
Retained Earnings-$266,700-$258,265-$246,452-$236,089
AOCI$0$0$0$0
Other Equity$270,333$269,791$265,237$262,039
Total Equity$3,741$11,616$18,868$26,030
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$17,811$21,732$34,757$43,870
Net Debt-$5,829-$3,548-$29,461-$29,954